Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

MicroRNAs can help regenerate hair by influencing stem cells and immune responses, but delivery challenges exist.

The treatment showed limited success in repigmenting hair for vitiligo-associated leukotrichia.

Including ineffective or unsafe doses in reviews can lead to misleading conclusions about alopecia areata treatments.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Platelet-rich plasma might help treat eczema by reducing inflammation and repairing the skin.

Biologic agents are effective for severe hidradenitis suppurativa when other treatments fail.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

New treatments offer hope for better managing hidradenitis suppurativa.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

The document is a detailed medical reference on skin and genetic disorders.

RV3466F lotion significantly reduces hair loss and improves acute telogen effluvium.

Laser therapy might help regrow hair in alopecia totalis better than steroids alone.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

The hair follicle dermal sheath is essential for hair shedding and needs to communicate with the outer root sheath for normal hair growth cycles.

PRC1 influences skin stem cell development by both turning genes on and off, affecting hair growth and skin cell types.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.

Finasteride helps female-pattern hair loss.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Skin aging can be slowed by targeting cells, hormones, and the microbiome.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Early diagnosis and targeted anti-inflammatory treatments can improve outcomes in androgenetic alopecia with perifollicular inflammation and fibrosis.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Current treatments for severe alopecia areata are unsatisfactory, highlighting the need for better options.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.